Roth David
Insider CIK 1599014 · INFI Chief Medical Officer · SYRS Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SYRS Syros Pharmaceuticals, Inc | S Sale | 2024-11-18 | 2024-11-20 | 12,099 | $0.20 | $2.4K | 0 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | M Exercise deriv | 2024-10-31 | 2024-11-04 | 18,875 | — | $0 | 0 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | F Tax w/h | 2024-10-31 | 2024-11-04 | 6,776 | $2.09 | $14.2K | 12,099 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | M Exercise | 2024-10-31 | 2024-11-04 | 18,875 | — | $0 | 18,875 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | S Sale | 2024-04-03 | 2024-04-05 | 10,451 | $4.95 | $51.7K | 0 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | S Sale | 2024-04-02 | 2024-04-02 | 150 | $4.98 | $747 | 10,451 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | F Tax w/h | 2024-04-01 | 2024-04-02 | 4,732 | $5.12 | $24.2K | 10,601 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | M Exercise deriv | 2024-03-31 | 2024-04-02 | 13,333 | — | $0 | 26,667 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | M Exercise deriv | 2024-03-31 | 2024-04-02 | 2,000 | — | $0 | 4,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | M Exercise | 2024-03-31 | 2024-04-02 | 2,000 | — | $0 | 2,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | M Exercise | 2024-03-31 | 2024-04-02 | 13,333 | — | $0 | 15,333 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | S Sale | 2023-12-12 | 2023-12-14 | 6,287 | $4.95 | $31.1K | 0 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | S Sale | 2023-12-06 | 2023-12-08 | 6,287 | $3.95 | $24.8K | 6,287 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | F Tax w/h | 2023-11-01 | 2023-11-02 | 6,301 | $2.22 | $14.0K | 12,574 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | M Exercise deriv | 2023-10-31 | 2023-11-02 | 18,875 | — | $0 | 18,875 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | M Exercise | 2023-10-31 | 2023-11-02 | 18,875 | — | $0 | 18,875 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | S Sale | 2023-07-31 | 2023-08-02 | 7,348 | $3.95 | $29.0K | 0 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | F Tax w/h | 2023-04-03 | 2023-04-04 | 623 | $2.58 | $1.6K | 7,348 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | M Exercise deriv | 2023-03-31 | 2023-04-04 | 2,000 | — | $0 | 6,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | M Exercise | 2023-03-31 | 2023-04-04 | 2,000 | — | $0 | 7,971 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2023-02-16 | 2023-02-21 | 40,000 | — | $0 | 40,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2022-10-06 | 2022-10-11 | 37,750 | — | $0 | 37,750 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2022-10-06 | 2022-10-11 | 49,750 | — | $0 | 49,750 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | F Tax w/h | 2022-04-01 | 2022-04-04 | 27,281 | $1.12 | $30.6K | 59,719 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2022-02-15 | 2022-02-17 | 200,000 | — | $0 | 200,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2022-02-15 | 2022-02-17 | 80,000 | — | $0 | 80,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2022-02-15 | 2022-02-17 | 125,000 | — | $0 | 125,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2021-02-17 | 2021-02-19 | 119,000 | — | $0 | 119,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2020-02-13 | 2020-02-14 | 94,000 | — | $0 | 94,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2019-02-12 | 2019-02-14 | 75,000 | — | $0 | 75,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award | 2019-02-12 | 2019-02-14 | 87,000 | — | $0 | 87,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2018-02-16 | 2018-02-21 | 75,000 | — | $0 | 75,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2017-02-10 | 2017-02-13 | 63,500 | — | $0 | 63,500 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | A Award deriv | 2015-01-14 | 2015-01-16 | 85,000 | — | $0 | 85,000 | SEC↗ |